Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Hologic, Inc.

Hologic, Inc. (HOLX) Stock Overview

Explore Hologic, Inc.’s financial performance, market position, analyst ratings, and future outlook.

HOLX●NASDAQ
HealthcareMedical - Instruments & Supplies
$76.01
$0.00(0.00%)
U.S. Market opens in 17h 36m

Hologic, Inc. (HOLX)

Meyka AI Score

Z

Key Financials

Market Cap17B
P/E Ratio31.28
EPS (TTM)$2.41
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$69.43

HOLX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Hologic, Inc. (NASDAQ: HOLX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Hologic, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HOLX on the NASDAQ shows an RSI of 0.00, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $69.43 for the NASDAQ listing.

Key metrics behind Hologic, Inc.'s NASDAQ-traded stock include a P/E ratio of 31.28 and a market capitalization of 17B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HOLX on the NASDAQ.

Price Performance (NASDAQ: HOLX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.60%
6-Month Change
2.58%
Year-to-Date (YTD) Change
2.04%
1-Year Change
37.13%
3-Year Change
-8.53%
5-Year Change
15.82%
All-Time (Max) Change
3080.33%

Contact Information

https://www.hologic.com
508 263 2900
250 Campus Drive, Marlborough, MA, 01752

Company Facts

70,630 Employees
IPO DateMar 1, 1990
CountryUS

Frequently Asked Questions